Literature DB >> 27993119

Pathophysiology of Myocardial Infarction and Acute Management Strategies.

Miha Tibaut1, Dusan Mekis2, Daniel Petrovic3.   

Abstract

On an annual basis, 13.2% of all deaths are attributable to coronary artery disease (CAD), which makes CAD - with 7.4 million deaths - the leading cause of death in the world. In this review, we discuss current knowledge in the pathophysiology of atherosclerosis with its progression to stable CAD and its destabilization and complication with thrombus formation - myocardial infarction (MI). Next, we describe mechanisms of myocardial cell death in MI, the ischemia-reperfusion injury, leftventricular remodeling and complications of MI. Furthermore, we add acute management strategies concentrating on medical therapy, a decision on the reperfusion strategy, timing and cardiac protection by ischemic preconditioning, post-conditioning and remote ischemic conditioning. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Atherosclerosis; coronary artery disease; management; medical therapy; myocardial conditioning; myocardial infarction; pathophysiology

Mesh:

Year:  2017        PMID: 27993119     DOI: 10.2174/1871525714666161216100553

Source DB:  PubMed          Journal:  Cardiovasc Hematol Agents Med Chem        ISSN: 1871-5257


  27 in total

1.  17-estradiol nanoparticles influence inflammatory response of myocardial infarction possibly through downregulation of miR-302b.

Authors:  Hao Ma; Dong Xu; Fei Liu; Qing Yao
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 2.  A Comprehensive Review on Schisandrin B and Its Biological Properties.

Authors:  M I Nasser; Shuoji Zhu; Chen Chen; Mingyi Zhao; Huanlei Huang; Ping Zhu
Journal:  Oxid Med Cell Longev       Date:  2020-03-14       Impact factor: 6.543

Review 3.  The Role of Exosomes and Exosomal MicroRNA in Cardiovascular Disease.

Authors:  Dongdong Zheng; Ming Huo; Bo Li; Weitie Wang; Hulin Piao; Yong Wang; Zhicheng Zhu; Dan Li; Tiance Wang; Kexiang Liu
Journal:  Front Cell Dev Biol       Date:  2021-01-12

4.  The C allele of the reactive oxygen species modulator 1 (ROMO1) polymorphism rs6060566 is a biomarker predicting coronary artery stenosis in Slovenian subjects with type 2 diabetes mellitus.

Authors:  Miha Tibaut; Sara Mankoč Ramuš; Daniel Petrovič
Journal:  BMC Med Genomics       Date:  2020-12-10       Impact factor: 3.063

Review 5.  Different Approaches in Therapy Aiming to Stabilize an Unstable Atherosclerotic Plaque.

Authors:  Michal Kowara; Agnieszka Cudnoch-Jedrzejewska
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

6.  Association of Myocardial Infarction with CDKN2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 Polymorphism in Slovenian Subjects with Type 2 Diabetes Mellitus.

Authors:  Miha Tibaut; Franjo Naji; Daniel Petrovič
Journal:  Genes (Basel)       Date:  2022-03-16       Impact factor: 4.096

7.  Peculiarities of Platelet Metabolism in Patients with Acute Coronary Syndrome with Anxiety-Depressive Disorders and Informativity of Enzymes in the Forecast of Development of Cardiovascular Complications.

Authors:  Natalya Yu Shimokhina; Andrey A Savchenko; Marina M Petrova
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-28

Review 8.  p38 MAPK Pathway in the Heart: New Insights in Health and Disease.

Authors:  Rafael Romero-Becerra; Ayelén M Santamans; Cintia Folgueira; Guadalupe Sabio
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

9.  Thymoquinone protects against cardiac mitochondrial DNA loss, oxidative stress, inflammation and apoptosis in isoproterenol-induced myocardial infarction in rats.

Authors:  Asmaa A Khalifa; Radwa M Rashad; Wessam F El-Hadidy
Journal:  Heliyon       Date:  2021-07-14

Review 10.  Advances in the mechanism and treatment of mitochondrial quality control involved in myocardial infarction.

Authors:  Chunfang Wang; Leiling Liu; Yishu Wang; Danyan Xu
Journal:  J Cell Mol Med       Date:  2021-06-23       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.